Fig. 1

Molecular dissection of breast cancer metastases. We collected breast cancer metastases from different sites, and we performed multiomic analyses, including whole exome sequencing (WES), bulk RNA sequencing (RNAseq), and miRNA profiling. The integrated analyses allowed to the identification of altered pathways in breast cancer metastases and novel therapeutic approaches that will be evaluated on patients-derived organoids